CLOSINGS: View Closings

First generic EpiPen gets FDA approval

The US Food and Drug Administration has ...

Posted: Aug 17, 2018 9:38 AM
Updated: Aug 17, 2018 9:38 AM

The US Food and Drug Administration has approved the first generic competitor to EpiPen and EpiPen Jr. for the emergency treatment of allergic reactions in adults and children.

The company Teva Pharmaceuticals gained approval to market the new generic drug, according to an announcement from the FDA on Thursday.

Allergies

Business and industry sectors

Business, economy and trade

Companies

Diseases and disorders

Government organizations - US

Health and medical

Mylan

Pharmaceutical industry

Pharmaceuticals and biotechnology

Pharmaceuticals and prescription drugs

US Department of Health and Human Services

US federal departments and agencies

US Food and Drug Administration

Immunology

Medical fields and specialties

Drug safety, efficacy and availability

Drug shortages

Brendan O'Grady, executive vice president who heads North America Commercial at Teva, noted in an emailed statement Thursday that the approval "marks an important step forward in bringing our patients additional prescription medications that have met the FDA's rigorous standards."

"We're applying our full resources to this important launch in the coming months and eager to begin supplying the market," the statement said.

No details are available regarding the cost of the new generic or precisely when it will be available.

'A lower-cost option'

The approval of the generic drug comes after EpiPens were added to the FDA's drug shortage list in May and two years after the maker of EpiPen, pharmaceutical company Mylan, increased costs of its product by more than 400%, leading to public outrage.

The newly approved generic offers an alternative for patients who, until now, have been able to use only the brand-name EpiPen.

"Today's approval of the first generic version of the most-widely prescribed epinephrine auto-injector in the U.S. is part of our longstanding commitment to advance access to lower cost, safe and effective generic alternatives once patents and other exclusivities no longer prevent approval," FDA Commissioner Dr. Scott Gottlieb said in the announcement.

"This approval means patients living with severe allergies who require constant access to life-saving epinephrine should have a lower-cost option, as well as another approved product to help protect against potential drug shortages," he said.

EpiPen is an auto-injector that delivers epinephrine, more commonly known as adrenaline, a hormone that can help relax muscles in the airways and tighten blood vessels. It can open the airways and reduce swelling during a severe allergic reaction.

Epinephrine injection is used along with emergency medical treatment for life-threatening reactions caused by allergies to insect bites or stings, foods, medications, latex or other causes.

Yet "the path to developing generic drug-device combination products like this one is challenging," Gottlieb said, because combination drugs consist of two parts: the drug, such as epinephrine, and the device, such as the auto-injector.

"We remain committed to doing our part to provide scientific and regulatory clarity for sponsors seeking to develop complex generics, as well as prioritize the approval of medicines with little or no generic competition," Gottlieb said.

This effort is part of the administration's overarching aim to "remove barriers to generic development," as outlined in its Drug Competition Action Plan, announced last year.

"We're especially committed to the development of generic copies of complex products," Gottlieb said. "These products can be hard to copy, and therefore sometimes don't face timely generic competition once patents and exclusivities are no longer a block to approval."

He added that "we're advancing new guidance for sponsors to make the development of generic versions of complex products more efficient, and we're prioritizing review of many complex generic drug applications."

What this means for back-to-school planning

Before the new generic, the only other FDA-approved alternatives to EpiPen were the brand products Auvi-Q and Adrenaclick. The newly approved option made by Teva is the only approved non-brand option.

The American Academy of Allergy, Asthma, and Immunology is "very pleased" with the approval of the new generic, said Dr. Robert Wood, president of the academy and director of pediatric allergy and immunology at Johns Hopkins Medicine in Baltimore.

"Any measures that can improve the availability and costs of these medications is a real benefit for our patients," Wood said.

"There have been recent concerns about shortages of EpiPens, which has been especially an issue as families are refilling prescriptions for back-to-school planning," he said. "We strongly support any measures than can help provide these lifesaving medications in a more cost-effective manner, especially given the concerns about the shortages of EpiPens."

Minnesota Coronavirus Cases

Data is updated nightly.

Cases: 289303

Reported Deaths: 3434
CountyCasesDeaths
Hennepin616511100
Ramsey25903487
Anoka20522218
Dakota20096183
Washington13066109
Stearns1291098
St. Louis7935101
Scott782754
Wright702436
Olmsted626134
Sherburne538640
Clay463856
Carver432213
Blue Earth387112
Rice386033
Kandiyohi373819
Crow Wing334631
Nobles298729
Chisago29358
Otter Tail282818
Benton278642
Winona258128
Mower241323
Douglas237631
Polk234423
Morrison219524
Lyon201911
McLeod195610
Beltrami194615
Becker187512
Goodhue185727
Steele17826
Itasca176124
Isanti174316
Todd171612
Carlton165710
Nicollet150823
Freeborn14465
Mille Lacs141630
Le Sueur138110
Waseca134011
Cass12849
Brown125011
Pine12458
Meeker11308
Roseau10503
Hubbard103822
Martin101920
Wabasha9611
Redwood83718
Dodge8060
Chippewa8057
Watonwan7984
Cottonwood7682
Renville75119
Sibley7414
Wadena7376
Aitkin69826
Rock6829
Pipestone67818
Houston6422
Fillmore6320
Yellow Medicine59311
Pennington5856
Kanabec54912
Murray5493
Swift5366
Faribault5081
Pope4990
Stevens4643
Clearwater4536
Marshall4438
Jackson4361
Unassigned38759
Lake3816
Koochiching3535
Wilkin3465
Lac qui Parle3383
Norman3227
Lincoln3171
Big Stone2841
Mahnomen2704
Grant2516
Red Lake2033
Kittson1917
Traverse1360
Lake of the Woods931
Cook600

Iowa Coronavirus Cases

Data is updated nightly.

Cases: 220032

Reported Deaths: 2282
CountyCasesDeaths
Polk32695327
Linn13801164
Scott1068881
Black Hawk10631132
Woodbury10061120
Johnson932336
Dubuque904191
Story666620
Dallas619957
Pottawattamie602967
Sioux362025
Webster348432
Marshall342044
Cerro Gordo340644
Clinton315939
Buena Vista297914
Des Moines278218
Muscatine278268
Warren270510
Plymouth265639
Wapello248671
Jones226913
Jasper210942
Marion200019
Lee195416
Carroll194621
Bremer188712
Henry17917
Crawford172015
Benton165116
Tama151540
Jackson140712
Delaware139621
Washington136914
Boone132911
Dickinson132710
Mahaska124127
Wright11986
Buchanan114110
Clay11184
Hardin111310
Page11074
Clayton10665
Hamilton10657
Harrison104328
Cedar103913
Calhoun10387
Fayette10149
Floyd100914
Mills10097
Kossuth10076
Lyon9988
Poweshiek97113
Butler9566
Winneshiek93311
Iowa91712
Winnebago89723
Hancock8417
Louisa83616
Grundy82611
Sac8207
Chickasaw8174
Cherokee7984
Cass78821
Mitchell7664
Appanoose76510
Allamakee76411
Shelby7469
Humboldt7435
Union7396
Emmet73624
Guthrie73015
Franklin71221
Jefferson6742
Madison6684
Palo Alto6244
Unassigned6170
Keokuk5647
Pocahontas5512
Howard5319
Greene5140
Osceola5101
Clarke4764
Ida46411
Taylor4513
Montgomery44610
Davis4455
Monroe43712
Adair4258
Monona4182
Fremont3523
Van Buren3524
Worth3470
Lucas3206
Decatur3120
Wayne2936
Audubon2922
Ringgold1982
Adams1612
Rochester
Overcast
30° wxIcon
Hi: 35° Lo: 26°
Feels Like: 22°
Mason City
Overcast
30° wxIcon
Hi: 39° Lo: 27°
Feels Like: 25°
Albert Lea
Clear
30° wxIcon
Hi: 36° Lo: 27°
Feels Like: 30°
Austin
Clear
30° wxIcon
Hi: 37° Lo: 27°
Feels Like: 30°
Charles City
Overcast
30° wxIcon
Hi: 39° Lo: 27°
Feels Like: 24°
Sunshine Returns for Friday
KIMT Radar
KIMT Eye in the sky

Community Events